GENEART technology platform and services
GENEART provides integrated system solutions for DNA engineering and processing based on the gene synthesis technology platform to deliver improved drugs and biotech products.
Companies and research institutions from both the pharmaceutical and biotech industries make use of GENEART's expertise in the development and production of DNA- and protein-based drugs and vaccines, and in identifying improved biocatalysts (enzymes). The GENEART service portfolio ranges from the production of optimized synthetic genes and the generation of gene variants and combinatorial biology (directed evolution) right through to the production of DNA-based agents.
The modular structure of the company's portfolio enables customers from industry or science to choose between having GENEART handle the entire process or selecting specific services when it comes to preparing a tailor-made (gene) product for subsequent application.
Print